JY
DSCI

Jeff Yass’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

Jeff Yass’s Portfolio DSCI Stock Details DSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-10,000
Closed -$116K – 10647
2014
Q2 		$116K Buy
+10,000
New +$103K ﹤0.01% 9380

Other funds holding DSCI

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
KAM
Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Jeff Yass's DSCI Position: Q1 2016 in Review

Jeff Yass sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q1 2016, closing a stake of 17,776 shares — an estimated $81K sold.

Jeff Yass first reported a position in DSCI in Q2 2014 and held it in 4 quarters. The position peaked at $872K in Q2 2015. 55 funds tracked by Wall St. Rank hold DSCI as of Q1 2016.

  • Jeff Yass reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q1 2016 after selling out during the quarter.
  • Jeff Yass sold 17,776 Derma Sciences, Inc. Common Stock (DE) shares in Q1 2016, an estimated $81K.
  • Jeff Yass first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q2 2014 and held it in 4 quarters.
  • Jeff Yass's Derma Sciences, Inc. Common Stock (DE) position peaked at $872K in Q2 2015.
  • 55 funds tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q1 2016.

Based on Susquehanna International Group's 13F filing for Q1 2016, filed 13 May 2016.